SPATS2

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, SPATS2 mutation is significantly associated with the RNA expression of many other genes, with 1,013 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible SPATS2-associated genes across cancer lineages are RNA5SP369, FBXO22, and CDT1. Each is linked with SPATS2 in more than 2 cancer types. Because this analysis shows association rather than direction, both SPATS2-to-partner and partner-to-SPATS2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP369 grouped by SPATS2-low versus SPATS2-high in SKCM.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SPATS2→partner) and Y-score (partner→SPATS2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SKCMRNA5SP369 →+0.174+4.671<.001.00433
UCECFBXO22 →+0.344+1.880.004.00532
UCECCDT1 →+0.718+3.606<.001.00132
UCECREEP4 →+0.491+2.258.001.00132
UCECMRM3 →+0.389+2.329.002.00332
UCECTIMM22 →+0.389+3.074<.001<.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 1,013 associations by consensus.

RNA5SP369 by SPATS2 expression — SKCM

Box plot of RNA5SP369 in SPATS2-low vs SPATS2-high samples in SKCM.

Explore this box plot interactively →

Exploration